Unlock instant, AI-driven research and patent intelligence for your innovation.
Use of arctigenin in preparing medicine for treating autoimmune hepatitis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of arctigenin and autoimmunity, applied in the field of medicine, can solve the problems such as the application of arctigenin that has not been reported, and achieve significant therapeutic and preventive effects, low price, and the effect of reducing liver tissue damage.
Active Publication Date: 2016-08-17
LUNAN PHARMA GROUP CORPORATION
View PDF1 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
It has been proved that arctigenin has stronger biological activity than arctiin, such as significant antibacterial, antiviral, antitumor, anti-PAF receptor and calcium antagonistic activities, but arctigenin has not been reported in the prior art Application in preparation of autoimmune hepatitis medicine
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
[0027] Add the prescribed amount of PEG-400 to arctigenin, stir to dissolve, add the prescribed amount of 0.9% sodiumchloride solution, stir evenly, adjust the pH to 3 with citric acid, add 0.5% activated carbon for needles, stir, and decarbonize, that is have to.
[0034] Add the prescribed amount of PEG-400 to arctigenin, stir to dissolve, add 0.9% sodiumchloride solution to 10L, stir evenly, adjust the pH to 4 with citric acid, add 0.5% activated carbon for needles, stir, and decarbonize to obtain . Embodiment 3 arctigenin injection
Embodiment 3
[0034] Add the prescribed amount of PEG-400 to arctigenin, stir to dissolve, add 0.9% sodiumchloride solution to 10L, stir evenly, adjust the pH to 4 with citric acid, add 0.5% activated carbon for needles, stir, and decarbonize to obtain . Embodiment 3 arctigenin injection
[0035] prescription:
[0036] Arctigenin 10g
[0037] PEG-400 1g
[0038] Add water for injection to 10L
[0039] Preparation Process:
[0040] Add the prescribed amount of PEG-400 to arctigenin, stir to dissolve, add water for injection to 10L, stir evenly, adjust the pH to 6.5 with citric acid, add 0.5% activated carbon for needles, stir, and decarbonize to obtain the product.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention provides a use of arctigenin in preparing a medicine for treating autoimmune liver diseases, and belongs to the field of medicine. Arctigenin is an effective traditional Chinese medicinemonomer obtained by extracting from a traditional Chinese medicine fructus arctii; when being used in treatment of the autoimmune liver diseases, arctigenin can significantly improve the proportion of immune cell factors of a patient, significantly reduces the aminotransferase level and the liver index of the patient, thereby playing effects of simultaneous treatment of principal and subordinate symptoms on the autoimmune liver diseases especially autoimmune hepatitis. Arctigenin has small toxic and side effect in a drug use process, and is definite in therapeutic effect, low in price and quite wide in medical application prospects.
Description
technical field [0001] The invention belongs to the field of medicine, and relates to a medical use of arctigenin, in particular to the use of arctigenin in preparing aglycone medicine for treating autoimmunity. Background technique [0002] Autoimmune liver disease is a type of autoimmune disease in which the liver is a relatively specific immunopathologically damaged organ. With the improvement of understanding and diagnosis level, the prevalence of autoimmune liver disease reported at home and abroad is increasing year by year, so it has been paid more and more attention and attention. It mainly includes: autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis, and any overlap syndrome between any two of these three diseases, often accompanied by extrahepatic immune diseases, and Diagnosis is based on specific biochemical abnormalities, autoantibodies, and dry tissue features. Among them, autoimmune hepatitis is the most common, and its liver ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More 
